Miransertib (ARQ 092) HCl
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors.
Supplier | Selleck Chemicals |
---|---|
Product # | S8339 |
Sku # | S8339-5mg |
Pricing | 5mg, $147.00 |